Heart rate reactivity, recovery, and endurance of the incremental shuttle walk test in patients prone to heart failure.
Fang-Fei WeiBeatrice MariottoniDe-Wei AnPierpaolo PellicoriYu-Ling YuJob A J VerdonschotChen LiuFozia Z AhmedJohannes PetutschniggPatrick RossignolStephane HeymansJoe CuthbertNicolas GirerdYan LiAndrew L ClarkTim S NawrotJoão Pedro FerreiraFaiez ZannadJohn G F ClelandJan A Staessennull nullPublished in: ESC heart failure (2024)
Spironolactone on top of usual treatment compared with usual treatment alone did not change resting HR, CHR, HRR and EE in response to ISWT. Beta-blockade might have concealed the effects of spironolactone. The current findings demonstrate that the ISWT, already used in a wide variety of pathological conditions, is a practical instrument to measure symptom-limited exercise capacity in patients prone to developing heart failure because of coronary heart disease.